Ryan Specialty (RYAN) Expected to Announce Earnings on Thursday

Ryan Specialty (NYSE:RYAN) is projected to issue its Q1 2025 quarterly earnings data after the market closes on Thursday, May 1st. Analysts expect the company to announce earnings of $0.40 per share and revenue of $680.80 million for the quarter.

Ryan Specialty (NYSE:RYAN) last announced its earnings results on Thursday, February 20th. The company reported $0.45 EPS for the quarter, missing analysts’ consensus estimates of $0.47 by ($0.02). Ryan Specialty had a net margin of 9.14% and a return on equity of 48.01%. The business had revenue of $663.53 million for the quarter, compared to analysts’ expectations of $658.80 million. On average, analysts expect Ryan Specialty to post $2 EPS for the current fiscal year and $3 EPS for the next fiscal year.

Ryan Specialty Stock Up 0.6 %

Shares of RYAN stock opened at $65.24 on Tuesday. Ryan Specialty has a 12 month low of $48.67 and a 12 month high of $77.16. The stock has a market cap of $17.09 billion, a P/E ratio of 94.55, a P/E/G ratio of 1.19 and a beta of 0.66. The company has a current ratio of 1.01, a quick ratio of 1.01 and a debt-to-equity ratio of 2.40. The company has a 50 day simple moving average of $70.35 and a two-hundred day simple moving average of $68.88.

Ryan Specialty Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Tuesday, March 4th were issued a dividend of $0.12 per share. This is a boost from Ryan Specialty’s previous quarterly dividend of $0.11. This represents a $0.48 dividend on an annualized basis and a yield of 0.74%. The ex-dividend date was Tuesday, March 4th. Ryan Specialty’s dividend payout ratio is currently 69.57%.

Insiders Place Their Bets

In other Ryan Specialty news, Director Nicholas Dominic Cortezi sold 31,409 shares of Ryan Specialty stock in a transaction on Wednesday, January 29th. The shares were sold at an average price of $65.64, for a total value of $2,061,686.76. Following the completion of the transaction, the director now directly owns 2,697 shares of the company’s stock, valued at $177,031.08. This trade represents a 92.09 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. Also, EVP Brendan Martin Mulshine sold 30,000 shares of Ryan Specialty stock in a transaction on Friday, March 14th. The stock was sold at an average price of $69.30, for a total transaction of $2,079,000.00. The disclosure for this sale can be found here. Corporate insiders own 11.10% of the company’s stock.

Analyst Upgrades and Downgrades

A number of analysts have recently issued reports on RYAN shares. Wells Fargo & Company reduced their price objective on shares of Ryan Specialty from $69.00 to $66.00 and set an “equal weight” rating for the company in a research note on Thursday, April 10th. Barclays reduced their price objective on shares of Ryan Specialty from $88.00 to $83.00 and set an “overweight” rating for the company in a research note on Friday, April 11th. Keefe, Bruyette & Woods reduced their price objective on shares of Ryan Specialty from $76.00 to $75.00 and set an “outperform” rating for the company in a research note on Wednesday, April 9th. Royal Bank of Canada reduced their price objective on shares of Ryan Specialty from $73.00 to $72.00 and set a “sector perform” rating for the company in a research note on Friday, February 21st. Finally, TD Cowen started coverage on shares of Ryan Specialty in a research report on Thursday, April 10th. They set a “buy” rating and a $89.00 target price for the company. One research analyst has rated the stock with a sell rating, five have given a hold rating and seven have given a buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus target price of $75.67.

About Ryan Specialty

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.